Megan Barnet

A/Prof Meg Barnet is a Staff Specialist in medical oncology treating gastrointestinal cancers, with special interests in immuno-oncology and genomic sequencing.

After completing her undergraduate degrees in biology and economics at Duke University, A/Prof Barnet returned to Australia and graduated medicine with Honours from the University of Sydney in 2008. She completed her general medical and physician training at Royal Prince Alfred Hospital and Chris O’Brien Lifehouse before moving to the St Vincent’s precinct to complete her PhD in immunology at the Garvan Institute.

A/Prof Barnet is a clinician researcher, having been awarded competitive funding including grants from NHMRC (Ideas), Australian Genomic Health Alliance, SVC Foundation, AMR and Tour de Cure to support her work, which focuses on germline determinants of response to immunotherapy. A/Prof Barnet is based in the immunology department at the Garvan Institute, consults from The Kinghorn Cancer Centre and St Vincent’s Clinic, chairs the multi-disciplinary meeting in upper gastrointestinal cancers, supervises within the Royal Australasian College of Physicians (RACP) and is a member of the St Vincent’s Human Research Ethics Committee (HREC). She is a conjoint Associate Professor within UNSW Sydney and Professor within UTS School of Biomedical Engineering, serves as Principal Investigator on numerous GI-focused clinical trials and is an advisor on research committees for Cancer Council NSW, Cancer Institute NSW and the Australian Gastro-Intestinal Trials Group.